Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

BackgroundThis study aimed to comprehensively explore the occurrence and risk factors for adverse events (AEs) and adverse drug reactions (ADRs) (especially for thrombocytopenia and bleeding) in Chinese patients with high bleeding risk (older adults, or complicated with diabetes mellitus or renal fu...

Full description

Bibliographic Details
Main Authors: Xiaoping Peng, Zhenyong Li, Dunheng Li, Zhongyin Li, Zhaohua Lu, Caidong Luo, Zheng Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
bivalirudin
percutaneous coronary intervention
high bleeding risk patients
adverse events and adverse drug reactions
thrombocytopenia and bleeding
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.821322/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.821322/full

Similar Items